コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 pyrolysis of citric acid in the presence of diethylenetriamine.
2 G), and d-mannaro-1,4:6,3-dilactone (M) with diethylenetriamine (1), triethylenetetramine (2), tetrae
3 ess, we studied the effects of the NO donors diethylenetriamine and spermine NONOate and the peroxyni
4 oteins, the complexes [Pt(dien)Cl]Cl (dien = diethylenetriamine) and [Pt(terpy)Cl]Cl (terpy = 2,2':6'
6 ical substrate N-1[3(trimethoxysilyl)propyl] diethylenetriamine (DETA) and fabricated microcantilever
7 -ammonioethyl)amino]diazen-1-ium-1,2-diolate diethylenetriamine elicited NO and ROI production, Ca(2+
8 0-tetraacetic acid monoamide (DOTA-MA), or a diethylenetriamine ligand (DETA-propanoic acid [PA]), fo
10 ive of the Eu3+-chelate of N-(p-benzoic acid)diethylenetriamine-N,N',N"-tetraacetic acid (DTTA), inco
11 Eu3+ chelate of N1-(p-isothiocyanatobenzyl)-diethylenetriamine-N1,N2,N3,N3-tetraacetic acid and then
12 atment of hCSCs with a widely used NO donor, diethylenetriamine nitric oxide adduct (DETA-NO), promot
13 N-acetylcysteine, the nitric oxide generator diethylenetriamine nitric oxide, 8-bromo-cGMP, and 8-(4-
14 nts, S-nitroso-N-acetylpenicillamine (SNAP), diethylenetriamine NO adduct (DETA-NO), and sodium nitro
16 pared with two other NO-releasing compounds, diethylenetriamine-NO and the organic nitrate, isosorbid
17 ced pharmacologically by giving the NO donor diethylenetriamine/NO (DETA/NO) (at a dose previously sh
18 ation of 2 structurally unrelated NO donors, diethylenetriamine/NO (DETA/NO) and S-nitroso-N-acetylpe
21 S-nitroso-N-penicillamine (SNAP, 25 muM) or diethylenetriamine-NONO (DETA-NO, 50 muM), exhibited ele
22 e tracheal epithelial) cells with 100 microm diethylenetriamine NONOate (DETA NONOate) for 24-96 h de
25 mmonioethyl) amino]diazen-1-ium-1,2-diolate (diethylenetriamine NONOate, DETA-NO) (1 mmol/liter) unde
27 njugated to isothiocyanato-2-benzyl-3-methyl-diethylenetriamine-penta-a cetic acid and labeled with e
28 ed and evaluated Eu(3+) complexes of several diethylenetriamine pentaacetate (DTPA)-monoamide ligands
29 converted into the corresponding aminobenzyl-diethylenetriamine pentaacetate conjugates 23 and 26.
30 stered (111)In-labeled alphavbeta6-specific (diethylenetriamine pentaacetate-tetra [DTPA]-A20FMDV2) o
31 ) after injection of 0.15 mmol/kg gadolinium diethylenetriamine-pentaacetate using an adjusted TI.
32 sively by the renal tubules, whereas (99m)Tc-diethylenetriamine pentaacetic acid ((99m)Tc-DTPA) is pr
33 1In-labeled 1,4-methyl-benzyl isothiocyanate diethylenetriamine pentaacetic acid (111In-MX-DTPA) BrE-
34 d to the 2-(4-isothiocyanatobenzyl)-6-methyl-diethylenetriamine pentaacetic acid (1B4M-DTPA, also kno
36 etic surfactant (Exosurf) on pulmonary 99mTc-diethylenetriamine pentaacetic acid (DTPA) aerosol depos
38 h ethylenediaminetetraacetic acid (EDTA) and diethylenetriamine pentaacetic acid (DTPA) were found to
39 erformed with a glomerular filtration agent, diethylenetriamine pentaacetic acid (DTPA), and a tubula
41 ods used for the preparation of (213Bi)CHX-A-diethylenetriamine pentaacetic acid (DTPA)-HuM195, an al
42 ised to a Pb(II)-loaded isothiocyanatobenzyl-diethylenetriamine pentaacetic acid (DTPA)-protein conju
43 detect retinal vascular leakage, gadolinium diethylenetriamine pentaacetic acid (Gd-DTPA) enhanced M
44 seen in MRI 5 to 7 minutes after gadolinium-diethylenetriamine pentaacetic acid (Gd-DTPA) injection,
46 globulin G had a higher T/B ratio than 111In-diethylenetriamine pentaacetic acid (p < 0.01) or 111In-
47 d significant acceleration of technetium-99m diethylenetriamine pentaacetic acid (Tc-99m DTPA) cleara
48 otracer of choice compared to technetium-99m diethylenetriamine pentaacetic acid (Tc-99m DTPA) for im
49 cted mutagenesis and metal chelators such as diethylenetriamine pentaacetic acid and deferoxamine, we
50 tized with the bifunctional chelator CHX-A''-diethylenetriamine pentaacetic acid and then bound to th
51 ined with MRPI after injection of gadolinium-diethylenetriamine pentaacetic acid at rest and during h
52 2*-weighted three-dimensional and gadolinium-diethylenetriamine pentaacetic acid T1-weighted MRI.
53 Simultaneous renal scans (technetium-99m diethylenetriamine pentaacetic acid) of the native and t
55 were conjugated with biotin and 111In-benzyl diethylenetriamine pentaacetic acid, and, at various tim
56 ation was detectable in levels of gadolinium-diethylenetriamine pentaacetic acid- or VCAM-MPIO-positi
57 Other less traditional probes include 99m Tc diethylenetriamine pentaacetic acid-galactosyl-human ser
59 uals underwent (125)I-iothalamate or (99m)Tc-diethylenetriamine-pentaacetic acid (DTPA) renal studies
60 iary (HB) phase with gadolinium-ethoxybenzyl-diethylenetriamine-pentaacetic acid (Gd-EOB-DTPA) with d
63 sing an alternative ventilation agent, 99mTc-diethylenetriamine pentacetic acid (DTPA) aerosol, and s
64 In contrast to the conventional MRI agent diethylenetriamine-pentatacetate gadolinium, which repor
67 fter delivery to hepatocytes, (111)In-benzyl-diethylenetriamine tetraacetic acid, was then used for r
68 H2valdien = N1,N3-bis(3-methoxysalicylidene) diethylenetriamine, the terminal ligand L = NO3(-) (1),
69 ine (TMSPEDA), N-[3-(trimethoxysilyl)propyl]-diethylenetriamine (TMSPETA), and tetraethoxyorthosilane
70 te (TMOS) and N'[3-(trimethoxysilyl)-propyl]-diethylenetriamine (TPDA) were used in a 1:1 mole ratio
71 ne (AE-APTES) and N-(3-trimethoxysilylpropyl)diethylenetriamine (TPDA), are used to generate the amin
72 rine, (ii) the low-temperature alkylation of diethylenetriamines with the triflate of benzyl glycolat
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。